Identification of glycoproteins in complex mixtures derived from either hum
an blood serum or a cancer cell line was achieved in a process involving th
e steps of (1) reduction and alkylation, (2) proteolysis of all proteins in
the mixture with trypsin, (3) affinity chromatographic selection of the gl
ycopeptides with an immobilized lectin, (4) direct transfer of the glycopep
tide fraction to a reversed-phase liquid chromatography (RPLC) column and f
urther fractionation by gradient elution, (5) matrix-assisted laser desorpt
ion ionization mass spectrometry of individual fractions collected from the
RPLC column, and (6) peptide identification based on a database search. Th
e types of glycoproteins analyzed were; (1) N-type glycoproteins of known p
rimary structure, (2) N-type glycoproteins of unknown structure, and (3) O-
type glycoproteins glycosylated with a single N-acetylglucosamine. Identifi
cation of peptides from complex mixtures was greatly facilitated by either
C-terminal sequencing with a carboxypeptidase mixture or by comparing chrom
atographic behavior and mass to standards, as in the case of a known protei
n. In addition, deglycosylation of peptides with N glycosidase F was necess
ary to identify N-type glycoproteins of unknown structure. The strength of
this approach is that it is fast and targets specific molecular species or
classes of glycoproteins for identification. The weakness is that it does n
ot discriminate between glycoforms. (C) 2001 Elsevier Science B.V. All righ
ts reserved.